Finzati - Logo
KALV logo

KalVista Pharmaceuticals, Inc.

KALV • Biotechnology
$26.99
— 0.00 (0.00%)
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$1.36B
Growth
-2.9%
Cash Flow
0/5
Trend
Negative
Evidence
Healthy liquidity · 5.58Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 15, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$26.99
Change0.00%
Shares Out50.54M
Market Cap$1.36B
Enterprise Value$1.34B
52W Range9.83 - 27.00
Beta-0.11
P/E-9.85
P/S11.77
P/B-503.12
P/FCF-57.49
EV/Sales11.54

Investment DNA

How strong this company looks for long-term investors

33
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Healthy liquidity · 5.58Weak profitability

Analyst view

Analyst sentiment and price target

KALV
Analyst sentiment
Based on 13 analyst votes · 2026-10-20
92/100
Bullish
Bullish
11
Hold
2
Bearish
0
Price Target
2026-06-23
Low
$27.00
Mean
$28.67
Median
$27.00
High
$32.00

Company Overview

IPO: 4/9/2015
Industry: Biotechnology
P/B i: -503.12
Debt / Equity i: -55.91
Operating Margin: -233.42%
Net Margin: -223.16%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: -55.91
Current Ratio: 5.58
Quick Ratio: 5.52
Status: Good

Insider Transactions

Recent executive and insider activity

⚠ 7 high-volume insider sells detected
Piekos Brian
Transaction: 06/11/2026
SELL
Change
-93,750
Price
Not reported
Filing
06/11/2026
Type
SELL
Piekos Brian
Transaction: 06/11/2026
SELL
Change
-100,000
Price
$11.87
Filing
06/11/2026
Type
SELL
Piekos Brian
Transaction: 06/11/2026
SELL
Change
-21,661
Price
Not reported
Filing
06/11/2026
Type
SELL